GSDMC and neoplasm: There is also evidence that the intravenous delivery of an immunotherapy based on Listeria monocytogenes encapsulated in red blood cell membrane was able to drive GSDMC-mediated pyroptosis in the tumour, successfully dampening the suppressive environment of the tumour (117).